Restoring Apoptosis in Pancreatic Cancer Cells by Targeting the Nuclear Factor-κB Signaling Pathway With the Anti-Epidermal Growth Factor Antibody IMC-C225
- 24 January 2003
- journal article
- Published by Elsevier BV in Journal of Gastrointestinal Surgery
- Vol. 7 (1), 37-43
- https://doi.org/10.1016/s1091-255x(02)00088-4
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- The function of multiple IκB : NF-κB complexes in the resistance of cancer cells to Taxol-induced apoptosisOncogene, 2002
- The Epidermal Growth Factor Receptor Engages Receptor Interacting Protein and Nuclear Factor-κB (NF-κB)-inducing Kinase to Activate NF-κBJournal of Biological Chemistry, 2001
- Inhibition of NF-κB sensitizes human pancreatic carcinoma cells to apoptosis induced by etoposide (VP16) or doxorubicinOncogene, 2001
- NEW EMBO MEMBERS' REVIEW: The ErbB signaling network: receptor heterodimerization in development and cancerThe EMBO Journal, 2000
- Overexpression of urokinase-type plasminogen activator in pancreatic adenocarcinoma is regulated by constitutively activated RelAOncogene, 1999
- HTLV-I Tax Protein Binds to MEKK1 to Stimulate IκB Kinase Activity and NF-κB ActivationCell, 1998
- Epidermal growth factor activation of NF-κB is mediated through IκBα degradation and intracellular free calciumOncogene, 1998
- The Epidermal Growth Factor Receptor Associates with and Recruits Phosphatidylinositol 3-Kinase to the Platelet-derived Growth Factor β ReceptorJournal of Biological Chemistry, 1998
- NF-κB Is Induced in the Nuclei of Cultured Rat Aortic Smooth Muscle Cells by Stimulation of Various Growth FactorsBiochemical and Biophysical Research Communications, 1996
- THE NF-κB AND IκB PROTEINS: New Discoveries and InsightsAnnual Review of Immunology, 1996